Wafa Samara, PharmD

Articles by Wafa Samara, PharmD

Wafa Samara, PharmD, Shares How Oncology Pharmacists Are Transforming Cancer Care at City of Hope

ByAlana Hippensteele, Lead Editor,Wafa Samara, PharmD

March 10th 2025

Wafa Samara, PharmD, vice president and chief pharmacy officer at City of Hope, highlights the vital role of oncology pharmacists at City of Hope in improving patient outcomes, conducting and leading research, and working as integral members of the multidisciplinary care team.

Latest Updated Articles

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 12th 2025 | Updated: June 16th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 10th 2025 | Updated: June 12th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: June 3rd 2025 | Updated: June 11th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Published: April 18th 2025 | Updated: April 21st 2025

Wafa Samara, PharmD

Articles by Wafa Samara, PharmD

Wafa Samara, PharmD, Shares How Oncology Pharmacists Are Transforming Cancer Care at City of Hope

Latest Updated Articles

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma

Effectively Managing Immunizations in the Long-Term Care Setting

IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma